Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-02 17:49:44 - browse：3537

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： AI can decode, harness the power of the humane immune system

WSS

FDA rejects Alnylam's heart disease treatment over insufficient data

Deposition: Sackler embraced plan to conceal OxyContin’s strength

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

My daughter's legacy lives on through her writing, phage therapy

Medical device trials still don't enroll enough women, study finds

Why age limits for politicians are a terrible idea

leisure time

Wikipedia

leisure time

Medicare details structure of new drug price negotiation program

Senate panel eyes new effort on drug shortages

Duchenne breakthrough therapy leaves behind pioneering families

NIH tests clinical research in primary care with $30 million program

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pharma companies must ensure equitable access to obesity drugs

The cancer drug shortage isn’t new — and neither are the solutions

Cigna wins case to block Amy Bricker's move to CVS

Medical leaders decry Supreme Court decision on affirmative action

ALS patient reclaims some autonomy thanks to wearable 'robot'

knowledge

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Bristol 'take

Histogen: Failed biotech offers rare public look inside

'Essentially witchcraft:' A former naturopath takes on the field

When women are denied an abortion, their children fare worse than peers

NIH tests clinical research in primary care with $30 million program

focus

Wikipedia

hotspot

focus